Wright Medical
Director, Biologics R and D
Dentsply Sirona Apr 2007 - Sep 2018
Corporate Director Biotechnology
Xylos Corporation Apr 2002 - Mar 2007
Director, R and D
Sulzermedica Sulzer Biologics 1999 - 2001
Manager, Bone Product Development and Support Services
Sulzermedica Sulzer Biologics 1993 - 1999
Product Development Engineer
Education:
Rutgers University 1985 - 1990
Doctorates, Doctor of Philosophy, Biomedical Engineering, Philosophy
Northwestern University 1981 - 1985
Bachelors, Bachelor of Science, Biomedical Engineering
Skills:
Product Development Iso 13485 Biotechnology R&D Design Control Medical Devices Biomaterials Biomedical Engineering Commercialization Product Launch Strategic Planning Osteobiologics Histology Fda Validation Cross Functional Team Leadership Quality System Research and Development Clinical Trials Healthcare Strategy Clinical Research Life Sciences Start Ups Verification and Validation Research Test Planning Regulatory Affairs Technology Transfer Management Leadership Contract Negotiation Regenerative Medicine Growth Strategies Project Management Materials Science
James J. Benedict - Arvada CO Christopher J. Damien - Denver CO
Assignee:
Centerpulse Biologics Inc. - Austin TX
International Classification:
C07K 100
US Classification:
623 2361, 514 21, 514 2, 514773, 514801, 435273
Abstract:
The present invention provides compositions for an implantable putty material for delivery of active compounds to a patient. More specifically, the present invention provides a material having a pH of between about 3 and 6 and possessing putty-like physical properties, wherein the composition of the material includes collagen and water. The present invention also provides a method for using the implantable putty material.
Dura Substitute And A Process For Producing The Same
Christopher James Damien - Newtown PA, US Heather Ann Beam - Penndel PA, US Gerry Ann Oster - Langhorne PA, US Frederick S. Wright - Ardmore PA, US Gonzalo Serafica - Langhorne PA, US
Assignee:
Synthes (USA) - West Chester PA
International Classification:
A61F 2/00 C12P 19/04 C12P 1/04
US Classification:
424424, 424428, 424488, 435 41
Abstract:
The invention relates to dura substitutes to be used as prostheses for dural defects in the field of neurosurgery and processes for producing the same. The present invention provides artificial dura mater materials comprising sheets of microbial-derived polysaccharide processed to have the necessary strength characteristics, conformability and physical properties.
Christopher James Damien - Newtown PA, US Heather Ann Beam - Penndel PA, US Gerry Ann Oster - Langhorne PA, US Frederic S. Wright - Ardmore PA, US Gonzalo Serafica - Langhorne PA, US
Assignee:
Synthes USA, LLC - West Chester PA
International Classification:
A61F 2/00 C12P 1/04 C12P 19/04
US Classification:
424424, 424428, 424488, 435 41
Abstract:
The invention relates to dura substitutes to be used as prostheses for dural defects in the field of neurosurgery and processes for producing the same. The present invention provides artificial dura mater materials comprising sheets of microbial-derived polysaccharide processed to have the necessary strength characteristics, conformability and physical properties.
This application describes a bioresorbable biocellulose suitable for medical and surgical applications. In particular, the invention describes periodate oxidized microbial cellulose that can be produced to have any mechanical and degradation profile, depending on the desired application of the oxidized cellulose.
Thermally Modified Microbial-Derived Cellulose For In Vivo Implantation
Christopher James Damien - Newtown PA, US Gerry Ann Oster - Langhorne PA, US Heather Ann Beam - Penndel PA, US
Assignee:
Xylos Corporation - Langhorne PA
International Classification:
A61K 31/715 A61F 2/00 C08B 1/00
US Classification:
514 57, 523113, 523114, 424425, 536 56, 536124
Abstract:
A thermally modified microbial-derived cellulose material is described for use as an implantable material in general surgery, plastic surgery and neurosurgery.
James J. Benedict - Arvada CO, US Christopher J. Damien - Denver CO, US
Assignee:
Zimmer Orthobiologics, Inc. - Austin TX
International Classification:
A61K 38/00
US Classification:
514 11, 514773, 424423
Abstract:
The present invention provides compositions for an implantable putty material for delivery of active compounds to a patient. More specifically, the present invention provides a material having a pH of between about 3 and 6 and possessing putty-like physical properties, wherein the composition of the material includes collagen and water. The present invention also provides a method for using the implantable putty material.
Improved collagen-based osteogenic materials are disclosed that have improved shaping and handling properties and which are easier for the health care practitioner to use than conventional implantable osteogenic materials. The new shaped implantable compositions or devices also provide a good matrix for the release of osteogenic substances and other desirable biologically active agents at the site of implantation to promote bone growth.
James Benedict - Arvada CO, US Christopher Damien - Denver CO, US
Assignee:
Centerpulse Biologics Inc.
International Classification:
A61K035/32
US Classification:
424/572000, 424/549000
Abstract:
The present invention provides compositions for an implantable putty material for delivery of active compounds to a patient. More specifically, the present invention provides a material having a pH of between about 3 and 6 and possessing putty-like physical properties, wherein the composition of the material includes collagen and water. The present invention also provides a method for using the implantable putty material.
Chris Damien (1988-1992), Cray Boggs (1970-1974), Stephen Matheny (1962-1966), Joseph Shaver (1969-1973), Jack Allen (1970-1974), Cynthia Jean Hays (1998-2002)